SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BMRA (Biomerica)
BMRA 2.480-7.6%Nov 4 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Leman who wrote (82)6/19/1998 1:50:00 PM
From: Johnny X   of 170
 
About your question on the AQB thread, (paraphrase) "will BMRA spike soon to $10": I wish I knew, of course! This is one of the solid small companies, spending most of its revenues on research and development and with only 3.9 million shares outstanding. I don't know when there will be another spike, though I'd guess it will occur when the prostate test is approved by the FDA. In the interim, I expect that the stock may be weak, but as earnings improve this quarter or next, and continues to get better as subsidiary Lancer's bottom-line gets better and BMRA improves its sales efforts -- then we will go back up to at least the $4 range. Timing... I admit ignorance as to when it will actually get the price strength it deserves.
I think the company should be applauded for taking its stock price seriously, for instance the buy-back of 1% of the stock.
The list of links are much appreciated. BTW, (speaking of links) you might want to check out AQB's new header, if you haven't already.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News